Meeder Asset Management Inc Harvard Bioscience Inc Transaction History

Meeder Asset Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 02, 2020	SELL	$2.75 - $4.2 $239 - $365	-87 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$1.42 - $3.29 $2,094 - $4,852	-1,475 Reduced 94.43%	87 $0
Q3 2019 Oct 17, 2019	BUY	$1.59 - $3.47 $640 - $1,398	403 Added 34.77%	1,562 $4,000
Q2 2019 Aug 05, 2019	BUY	$1.93 - $4.59 $216 - $514	112 Added 10.7%	1,159 $2,000
Q1 2019 Apr 16, 2019	SELL	$2.77 - $4.38 $15,512 - $24,528	-5,600 Reduced 84.25%	1,047 $5,000
Q4 2018 Jan 17, 2019	BUY	$3.03 - $5.0 $5,093 - $8,405	1,681 Added 33.85%	6,647 $20,000
Q3 2018 Nov 02, 2018	BUY	$5.0 - $6.65 $24,830 - $33,023	4,966 New	4,966 $0

31.5M

700

2.1K

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $87.4M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.